Spot Trading’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$9.92M Sell
155,600
-145,900
-48% -$8.52M 0.17% 104
2017
Q2
$16.8M Buy
301,500
+105,400
+54% +$5.74M 0.33% 28
2017
Q1
$10.7M Buy
196,100
+40,700
+26% +$2.23M 0.35% 29
2016
Q4
$9.08M Buy
155,400
+124,500
+403% +$6.81M 0.21% 85
2016
Q3
$1.67M Sell
30,900
-1,100
-3% -$70.7K 0.03% 760
2016
Q2
$2.35M Sell
32,000
-18,400
-37% -$1.3M 0.04% 603
2016
Q1
$3.22M Sell
50,400
-161,400
-76% -$10.2M 0.06% 451
2015
Q4
$14.6M Buy
211,800
+121,500
+135% +$8.03M 0.15% 145
2015
Q3
$5.35M Buy
90,300
+64,700
+253% +$4.1M 0.05% 483
2015
Q2
$1.7M Sell
25,600
-35,100
-58% -$2.31M 0.02% 1241
2015
Q1
$3.92M Sell
60,700
-76,900
-56% -$4.81M 0.04% 689
2014
Q4
$8.12M Buy
137,600
+8,000
+6% +$451K 0.05% 537
2014
Q3
$6.63M Sell
129,600
-7,300
-5% -$365K 0.03% 769
2014
Q2
$6.64M Sell
136,900
-22,400
-14% -$1.1M 0.03% 782
2014
Q1
$8.28M Sell
159,300
-138,400
-46% -$7.36M 0.05% 555
2013
Q4
$15.8M Buy
297,700
+113,600
+62% +$5.79M 0.08% 251
2013
Q3
$8.52M Buy
184,100
+90,200
+96% +$3.96M 0.05% 440
2013
Q2
$4.2M Buy
+93,900
New +$4.08M 0.03% 826

Other funds holding BMY

Spot Trading's BMY Position: Q3 2017 in Review

Spot Trading reduced its Bristol-Myers Squibb (BMY) stake by 80% in Q3 2017, selling an estimated $8.44M and leaving 36,605 shares worth $2.33M. The position accounts for 0.04% of the portfolio, ranked #641.

Spot Trading first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $10.1M in Q2 2017. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Spot Trading held 36,605 shares of Bristol-Myers Squibb worth $2.33M as of Q3 2017.
  • Spot Trading sold 144,522 Bristol-Myers Squibb shares in Q3 2017, an estimated $8.44M.
  • Bristol-Myers Squibb made up 0.04% of Spot Trading's portfolio in Q3 2017, its #641 holding.
  • Spot Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
  • Spot Trading's Bristol-Myers Squibb position peaked at $10.1M in Q2 2017.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.